title: Management of haemorrhagic bullous lesions in Henoch-Schonlein purpura: is there any consensus?
abstract: Henoch-Schonlein purpura (HSP) is the most common form of vasculitis affecting children. The cutaneous manifestations classically present as urticarial wheals, erythematous maculopapules, petechiae, purpura or oedema, which characteristically involve the lower extremities and buttocks. Haemorrhagic bullous lesions are a recognized but rare occurrence with HSP in children. We report a 6-year-old boy with HSP who developed extensive haemorrhagic bullae requiring dermatological referral and treatment. Scrutiny of our management and available literature reveals a lack of consensus in the management of extensive cutaneous involvement in HSP.
authors: Birmingham Children's Hospital, Birmingham, UK. drsabihak@doctors.org.uk
authors: Sabiha
authors: S
authors: Kausar
authors: Aparna
authors: A
authors: Yalamanchili
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001768:Blister / Q000175:diagnosis* / Q000628:therapy*; D002648:Child; D003131:Combined Modality Therapy; D003622:Dapsone / Q000627:therapeutic use; D018450:Disease Progression; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D011695:IgA Vasculitis / Q000175:diagnosis* / Q000628:therapy*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D010781:Photography; D010951:Plasma Exchange / Q000379:methods; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D003622:Dapsone